Unilever (UN, UL) is set to acquire the Fluocaril and Parogencyl brands from Procter & Gamble (NYSE:PG) for an undisclosed amount.
Fluocaril specializes in protecting teeth against cavities, while Parogencyl is formulated to address gum issues.
«With their powerful brand heritage, high awareness and sound reputation amongst dentists, these brands are a great complement to Unilever’s existing oral care portfolio,» notes Unilever on the new additions.
The acquisition of the brands is slated to close in Q2.
